Confidential1

Taiga BioActives: The Natural Investment

2

Company Focus

Confidential

• Taiga BioActives Inc. is positioning itself as a Canadian leader in the natural personal care and natural health products space.

• Our inspiration and our company name come from “The Taiga”, another word for the Boreal Forest.

• Our corporate commitments focus on nature as well as the inherent value and healing properties of botanical materials.

• We pride ourselves on meeting consumer needs by turning fresh and innovative ideas into purpose–filled, effective natural products.

• As part of our operating mandate, we actively seek ways to:• Support and preserve the Boreal Forest, while reducing our carbon

footprint through aggressive recycling and tree planting programs, and• Enhance the comfort and lifestyles of natural product users through our

innovative and patented product portfolio.

Why Natural Products?

Confidential 3

.

• A 2010 Ipsos Reid survey shows that 73% of Canadians regularly use natural health products (NHPs).

• The Natural Marketing Institute (NMI) estimates a $290 billion U.S. marketplace for goods and services focused on health, the environment, social justice, personal development and sustainable living.

• Organic Monitor Organic projects global sales of natural personal care products to reach $14.7 billion in 2017.

• In 2008 natural and organic sales of skin care accounted for 28.2% of the total skin care sales, growing at 8% per year vs. 2.3% per year growth for mainstream personal care products.

Why Botanicals?

Confidential 4

• Botanicals are 100% natural, plants and parts of plants including leaves, stems, extracts and oils

• Botanicals are the single largest resource for novel medications known to mankind

• A Kline and Company 2009 study found that botanicals were growing at 8% compared to 5% for other actives in US and Europe

Opium Poppy - source of Morphine for pain

Foxglove -source of Digitalis for heart stimulant

White Willow Bark - original source of Aspirin

Why Taiga?

Confidential 5

• Currently launching a novel, botanical, 9 SKU line of botanical personal care products built on a Cucumber Extract and Cornflower Water platform and supported by a successful year-long test market.

• Active current investors who are excited by Taiga’s innovative botanical focus, research and product pipeline.

• Active and productive R&D program:• 12 more SKUs for the personal care line already formulated• A first-to-market all natural, botanical, topical treatment for a highly prevalent

condition that has successfully demonstrated efficacy in two levels of in vitro testing and has attracted interest from a big 5 pharmaceutical company

• A natural botanical topical alternative for a high volume everyday health issue is already formulated

• Cold sore formulation with NPN market-ready• Currently researching novel applications for unique botanicals

• Industry experts attracted to our Board.

• Outstanding management team.

6

Priority 1: Generate Near-Term Revenues through Novel Botanical Personal Care Product Line

Priority 2: Generate Longer-Term Revenues and IP from Botanical Natural Health Products (NHPs) for the Treatment of Common and Intractable Medical Conditions

Taiga’s Company Priorities

Confidential

Confidential 7

Product category Major competitors Taiga AdvantagePersonal care Canada: Aveda (Estee Lauder),

Burt’s Bees (Clorox)International: WeledaTraditional: L’Oreal, Estee Lauder, P&G, JnJ

More efficacious, more natural at 99.7% and 88.35% organic vs. Burt’s Bees on comparative products 99.2% natural and no organic

Consumer medicated skin care

Multiple non-natural examples (Johnson and Johnson market leader)

NPN, proven claims, completely natural, highest efficacy, no known side effects

Serious conditions and diseases

Multiple players focused on conventional therapies such as antibiotics, steroids etc.(Pfizer, GlaxoSmithKline etc.)

No known side effects, completely natural, highest efficacy

Competitive Landscape

8Confidential

Sales Forecast

Personal CareNHP

2013 2014 2015 2016 2017 20180

5000

10000

15000

20000

25000

30000

$ (000)

Confidential 9

The Taiga Team – ManagementJohn Hiebert, President and CEO• Successful entrepreneur with a solid track record creating and building successful

businesses• CEO with Taiga since 2006, leading the development of proprietary and value-added

opportunities• Champion of the benefits of botanicals

Janet Hyde MBA – Marketing and New Product Development• Expert in market opportunity identification, brand development, marketing strategy and

retailing• Clients have included Saponin Inc., Little Potato Company, Agricore United• MBA, Ivey School of Business, University of Western Ontario

Dr. Bhavin Rawal – Science Officer• Expertise in new product development with Innovotech and Clinexus in Edmonton • Several research-related positions in Toronto • PhD in microbiology from Sardar Patel University with post-doctoral work in Germany

10

The Taiga Team – Board of Directors

Confidential

Rick Smith, Board Chair Former President and CEO of Dow AgroSciences Canada Inc., Director of AVAC, Director of Commercial Solutions Inc. (TSX); Co-Chair BioAlberta

Dr. David Cox, Director15 years experience as CEO in the biotech/pharmaceutical/Agri-food industries including Radient Technologies, TEC Edmonton, Quest Pharmatech Inc., KC Avicenna. , SYNSORB Biotech Inc., Apotex. PhD in Microbiology from Leeds University (England)

Fred Shaw, DirectorPresident Centra Holdings Inc., former Partner Colt Engineering

Paul Heyens, DirectorPresident and CEO Alberta Glass Company Inc.

John Hiebert, DirectorPresident and CEO, Taiga BioActives Inc.

11

Current Offering … $2.5 Million in Equity Placement

Confidential

• These funds will be primarily used to: • Drive additional product introductions,• Ramp up sales and marketing efforts, • Expand new product development, and• Address key professional staffing requirements.

• Current shareholders will participate in this offering and are open to negotiation.

• Non-dilutive investment of $1M as well as additional government funding in the same range will be attracted by this investment.

12Confidential

Taiga’s Assets

• Trademarks on brands including Max/Effects Naturals™ and Refresh Naturals™

• Important trade secrets relating to product blending and formulations

• NPN 02247131 on Cold Sore formulation

• Positive IP opportunities on natural health products defined by IP specialist

• Prospects for IP from previously unknown botanical treatments for various conditions and diseases

13Confidential

Non-Dilutive Funding Track Record

Taiga’s has been successful in attracting non-dilutive funds:

• $380K project funding from Growing Forward to support product development.

• $50K funding from IRAP for testing UTI formulation. An additional $50K project is currently awaiting approval.

• $60K funding from Alberta Bio-based Processing Incentive Grant Program and Alberta Agriculture to assess new product development opportunities.

14

Investment Highlights

Confidential

• Innovative and nimble natural products company in attractive botanicals space.

• Anticipate company value of $70 Million by 2018.

• Prototype product is generating revenue with enthusiastic customer following in test market.

• Strong product pipeline with increasing IP potential.

• Significant prior angel investment leading to substantial de-risking.

• Clean capital structure.

• Strong potential for non-dilutive leveraging by government and other funders.

• Opportunity for early participation and significant upside for investors.

15Confidential

John HiebertPresident & CEOTaiga BioActives Inc.6 – 2616 16th Street NECalgary Alberta Canada 72E 7J8Phone: +1-403-863-0200Email: johnh@taigabioactives.comwww.taigabioactives.com

Taiga BioActives: The Natural Investment